DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
Recruiting
GE Healthcare
Early Phase 1
2016-11-07
This early phase I trial studies how well dynamic contrast enhanced molecular resonance
imaging (DCE-MRI) and technetium-Tc99m sestamibi molecular breast imaging (MBI) work in
assessing tumor response to chemotherapy in patients with triple negative breast cancer
(TNBC) who are undergoing chemotherapy. Investigational imaging scans such as MBI and DCE-MRI
may help researchers predict which patients may respond to treatment.
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
Recruiting
National Cancer Institute (NCI)
Early Phase 1
2016-11-07
This early phase I trial studies how well dynamic contrast enhanced molecular resonance
imaging (DCE-MRI) and technetium-Tc99m sestamibi molecular breast imaging (MBI) work in
assessing tumor response to chemotherapy in patients with triple negative breast cancer
(TNBC) who are undergoing chemotherapy. Investigational imaging scans such as MBI and DCE-MRI
may help researchers predict which patients may respond to treatment.
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
Recruiting
M.D. Anderson Cancer Center
Early Phase 1
2016-11-07
This early phase I trial studies how well dynamic contrast enhanced molecular resonance
imaging (DCE-MRI) and technetium-Tc99m sestamibi molecular breast imaging (MBI) work in
assessing tumor response to chemotherapy in patients with triple negative breast cancer
(TNBC) who are undergoing chemotherapy. Investigational imaging scans such as MBI and DCE-MRI
may help researchers predict which patients may respond to treatment.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
